Boston Scientific elects Jessica L. Mega and Susan E. Morano to board of directors

BOSTON SCIENTIFIC CORP

Dr. Mega is co-founder of Verily Life Sciences (Alphabet) and former chief medical officer; cardiologist at Brigham & Women's.
Ms. Morano was VP of Business Development and Strategic Operations at Johnson & Johnson MedTech until Feb 2023.
Board expanded from 10 to 11; appointments effective June 27, 2023, with prorated cash retainer ~$97,715 and equity award ~$174,188.
Dr. Mega joins Compensation and Risk Committees; Ms. Morano joins Audit and Nominating & Governance Committees.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jessica L. Mega

director

BSX · BOSTON SCIENTIFIC CORP

Effective: 2023-06-27
Filed: June 27, 2023, 7:59 PM ET

appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.

Appointed

Susan E. Morano

director

BSX · BOSTON SCIENTIFIC CORP

Effective: 2023-06-27
Filed: June 27, 2023, 7:59 PM ET

appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jessica L. Mega was appointed as director at BOSTON SCIENTIFIC CORP.

Action: appointed
Role: director

Exact text from the filing

appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Susan E. Morano was appointed as director at BOSTON SCIENTIFIC CORP.

Action: appointed
Role: director

Exact text from the filing

appointed each of Jessica L. Mega, MD, MPH and Susan E. Morano to be a director of the Company, to hold office until the next annual meeting of stockholders, in each case, effective June 27, 2023.

View on SEC.gov

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-23-000038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.